Curcumin-Modified Selenium Nanoparticles Improve S180 Tumour Therapy in Mice by Regulating the Gut Microbiota and Chemotherapy [Corrigendum]

Zhang R, Zhang W, Zhang Q, et al. Int J Nanomedicine. 2024;19:13653–13669. https://doi.org/10.2147/IJN.S476686

The authors have advised that Figure 5E on page 13664 was mistakenly copied from the control group causing the HE staining image of the heart in the Cur/Se NPs group to be duplicated.

The correct Figure 5 is shown below.

Figure 5 Anti-S180 tumour study in vivo. (a) S180 tumour growth curves. (b) Body weight curves. (c) Photograph of excised tumours. (d) Excised tumour weights on Day 10. (e) HE staining of the organs. The results are expressed as the means ± SDs (n = 6). *P < 0.05. **P < 0.01.

The authors apologize for this error.

Read the original article

© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.